Pentylenetetrazol

Pentylenetetrazol, also known as PTZ, is a drug that is primarily used as a circulatory and respiratory stimulant. High doses of this medication can cause seizure, and it was therefore used for many years as a method of inducing seizures in neurology to aid in the diagnosis and treatment of certain neurological disorders.

History

Pentylenetetrazol was first synthesized in the 1920s. It was used in the 1930s and 1940s as a treatment for schizophrenia and other mental illnesses through a process known as cardiazol shock therapy. This use was largely discontinued in the 1950s with the introduction of electroconvulsive therapy and other treatments.

Medical Uses

Pentylenetetrazol has been used historically as a circulatory and respiratory stimulant. It has also been used to induce seizures for diagnostic purposes. However, its use for these purposes has declined due to the risks associated with seizure induction and the development of safer alternatives.

Pharmacology

Pentylenetetrazol is a GABA antagonist, which means it inhibits the action of the neurotransmitter GABA in the brain. This inhibition can lead to increased neuronal activity, which can result in seizures in high doses.

Side Effects

The most common side effect of pentylenetetrazol is seizures, which can be severe and life-threatening. Other side effects can include anxiety, restlessness, and tachycardia.

See Also

• Cardiazol shock therapy
• Electroconvulsive therapy
• GABA antagonist

Pentylenetetrazol Resources
Latest articles Most recent articles Ongoing trials	Wikipedia